ライフサイエンスコーパス: be considered for

1 For 2005 to 2007, process-only reporting was considered; for 2008 to 2012, process and mortality

2 f mortality, all patients with an SRM should be considered for a biopsy when the results may alter ma

3 th common and low-frequency variants need to be considered for a comprehensive understanding of the g

4 rentiation and genetic tradeoffs, and should be considered for a full understanding of the ecology an

5 ment outside of the alveolar process need to be considered for a gingival augmentation procedure.

6 Susceptibility testing for colistin should be considered for A. baumannii identified from CMS-exper

7 of monolithic dealloyed materials at present being considered for a variety of applications.

8 (PVCs) or VT and tachycardiomyopathy should be considered for ablation before ICD implantation becau

9 rain source and processing conditions should be considered for accurate gluten analysis.

10 ng MAT into primary care settings that could be considered for adaptation across diverse health care

11 ing for screening for genetic HLH and should be considered for addition to current HLH criteria.

12 mal growth factor receptor 2 (HER2) who were being considered for adjuvant systemic treatment with an

13 This intervention should be considered for adoption in the public sector in Afric

14 oral immunotherapy is a treatment option to be considered for adults with food allergy who were not

15 Oral anticoagulation should be considered for AF patients with 1 additional stroke r

16 lopment of formal mentorship programs should be considered for all academic departments of surgery.

17 Total gastrectomy should be considered for all CDH1 mutation carriers because of

18 nistic infections or transfusions and should be considered for all FA patients after the onset of mar

19 ing and testing with a multigene panel could be considered for all patients with early-onset CRC.

20 n to prophylactic cranial irradiation should be considered for all patients with ES-SCLC who respond

21 ucing subsequent harm after admission should be considered for all types of adversity-related injury,

22 testing with multigene cancer panels should be considered for all young patients with CRC.

23 development stage, and harvest stage should be considered for alternative uses of end-products with

24 ng within the first 2 years from ASCT should be considered for an allogeneic transplantation.

25 undergone primary SG within a 7-year period were considered for analysis.

26 death and nonfatal acute coronary syndromes) were considered for analysis.

27 at women with high-risk thrombophilia should be considered for antenatal thromboprophylaxis regardles

28 a high-risk metastasis subgroup that should be considered for anti-TGFbeta therapy in adjuvant setti

29 ility in such materials is crucial when they are considered for application as filters in CWs.

30 Therefore, it has been considered for applications in numerous research fi

31 SiC is considered for applications in advanced nuclear syste

32 stremission stem cell transplantation should be considered for appropriate patients.

33 thought to be therapeutically inefficient to be considered for ATT.

34 nting with a family history of cancer should be considered for BAP1 genetic testing to identify those

35 ssing neighborhood-level risk factors should be considered for better targeting of IPV prevention.

36 5 mammographic microcalcifications, but can be considered for BI-RADS 4 mammographic microcalcificat

37 , 2D and 3D) with printing capabilities have been considered for bio and medical applications.

38 Flexibility was considered for both ligands and peptides and each pe

39 vant treatment with aromatase inhibitors can be considered for breast cancer patients who have T-scor

40 temperature affects these life stages should be considered for broadly understanding the ecological c

41 family other than the Solanaceae, and could be considered for canker control.

42 Mesenchymal stem cells (MSCs) are considered for cartilage engineering given their abi

43 in combination with current treatment should be considered for certain neuroblastomas.

44 wth factor receptor 2-negative breast cancer being considered for chemotherapy were eligible.

45 Once daily, low-dose ferrous sulfate should be considered for children with nutritional iron-deficie

46 addition of denosumab, this treatment should be considered for clinical practice.

47 ministration of CPA is needed before CPA can be considered for clinical translation.

48 conclude that PAMs and NAMs of mGluRs should be considered for clinical trials.

49 have a > 10% risk of CNS relapse and should be considered for CNS-directed investigations and prophy

50 ld be routinely assessed in patients who are being considered for complex surgery.

51 or enhanced biodegradation of 1,4-dioxane is being considered for contaminated groundwater and indust

52 sticity and multi-axial stresses should also be considered for crack nucleation under indentation, ev

53 f aBMSCs, and thus, their clinical use could be considered for craniofacial regenerative therapies.

54 ecommended after device implantation but may be considered for CRT nonresponders.

55 assessments, and these patients should still be considered for deep brain stimulation.

56 icity and suggest that these features should be considered for design of both safer AAV vectors and g

57 ssful clearance of FMDV infection and should be considered for development of next-generation vaccine

58 Peculiarities of eigenvalue behaviour are considered for different permittivity ranges of loss

59 However, statins have not been considered for DMD, or other muscular dystrophies,

60 by x-ray crystallography) protein structures were considered for docking.

61 boelastography-directed selective use should be considered for documented HF.

62 y is still present, and these patients could be considered for downgrade from CRT-defibrillator to CR

63 d for surgical repair and routine use should be considered for EA.

64 landfilling, and multiple performance levels were considered for each option.

65 light the complexity of factors that need to be considered for efficient antigen delivery and present

66 ysteine protease inhibitors, oryzacystatins, were considered for efficient production of bioactive pe

67 Empiric treatment should be considered for ELBW infants delivered vaginally who h

68 rugs and argues that ASCT should continue to be considered for eligible patients.

69 e in preventing this complication and should be considered for emergent operations in an effort to im

70 r atmospheric organic chemicals which should be considered for emissions monitoring and impact assess

71 rum of antifungal coverage and, as such, may be considered for empiric therapy of endophthalmitis cau

72 This information allows more options to be considered for empiric therapy, at least for some pat

73 ion in stage I and II invasive breast cancer was considered for endorsement.

74 , it is a series of four subsets that should be considered for enrollment in clinical trials and for

75 sponse and safety after 12 weeks in order to be considered for enrolment into the extension study.

76 health status, and their interactions should be considered for estimating mortality risk; however, th

77 H5N1) influenza infection in mice and should be considered for evaluation in a clinical setting.

78 trolled trials with moderate to high quality were considered for evaluation of effectiveness.

79 itative clinical assessment and they need to be considered, for example, for clinical trials.

80 Pharmacokinetics should be considered; for example, nonpersistent, semivolatile

81 and that patients with TP53 mutations should be considered for experimental frontline trials explorin

82 Computational hits were considered for experimental validation based on the

83 esults, we propose that recycled jute should be considered for fabrication of high-performance flexib

84 Patients were considered for FMT if they had low vision in the fe

85 aemia whose blast cells express CD117 should be considered for forthcoming clinical trials of ibrutin

86 We suggest our methodology could be considered for further developments in theoretical tr

87 those with normal renal function, and should be considered for further investigation and treatment.

88 protective HCV vaccine candidate that should be considered for further preclinical and clinical devel

89 results, we believe that compound 10 should be considered for further preclinical evaluations for th

90 tives and 6,742 potential actives (20.8%) to be considered for further testing.

91 or high bioaccumulation and toxicity, should be considered for future animal and human studies.

92 ation, we propose that milder cooling should be considered for future clinical trials.

93 l memory after infection or vaccination must be considered for future design of effective influenza v

94 V for the detection of metastases and should be considered for future oncologic imaging clinical tria

95 Patient-reported outcomes should be considered for future studies on this topic.

96 arget these provirus-harboring cells need to be considered for future therapies aimed toward HIV-1 cu

97 3 in protecting against all-cause HTP should be considered for future vaccine policies.

98 e antigenic type or immunotype that needs to be considered for future vaccine strategies against huma

99 lthy lifestyle during early pregnancy should be considered for GDM prevention.

100 on greatly expand the genome space that must be considered for gene regulatory analyses in mycobacter

101 iagnosis or family history of cancer, should be considered for germline genetic testing of BRCA1 and

102 To be considered for HCT, patients must have HIV infection

103 Veliparib-carboplatin plus standard therapy was considered for HER2-negative tumors and was therefor

104 duction of S Typhi conjugate vaccines should be considered for high-incidence settings, such as those

105 utine post-discharge pharmacoprophylaxis can be considered for high-risk patients (ie, VTE risk >0.4%

106 ial to be automated and parallelized, it can be considered for high-throughput screening in metabolic

107 Anal cancer screening should be considered for HIV-positive women as part of their ro

108 Pending validation, this technology should be considered for human use.

109 ggest that a multiple allergen system should be considered for immunotherapy instead of a mono-allerg

110 rmance of this dual rapid test, which should be considered for implementation to increase screening c

111 dies, as potential functional overlap has to be considered for in vitro and in vivo studies.

112 Philosophy of care discussions should be considered for inclusion as a potential quality of ca

113 ion are at lower risk for relapse and should be considered for inclusion in a randomized clinical tri

114 linical trials, and depth of invasion should be considered for inclusion in TNM staging criteria.

115 sk individuals identified by this tool could be considered for inclusion into trials exploring preven

116 Serotype IV should be considered for inclusion, with evidence of capsular s

117 otype-1 HCV and a low viral load at baseline were considered for inclusion (n = 233).

118 Studies were considered for inclusion if they reported procedura

119 ent of adults with major depressive disorder were considered for inclusion in the meta-analysis.

120 e practice for treatment with mandibular ODs were considered for inclusion in this study.

121 at least 2 aflibercept injections afterward were considered for inclusion.

122 s who had Doppler echocardiography performed were considered for inclusion.

123 monia, or sterile fluid and tissue infection were considered for inclusion.

124 ved manipulation of the discussed mechanisms were considered for inclusion.

125 eneration DES, second-generation DES or BMS) were considered for inclusion.

126 tween January 1, 1990, and October 15, 2010, were considered for inclusion.

127 meta-analyses, reviews) in English or French were considered for inclusion.

128 ain injury requiring invasive ICP monitoring were considered for inclusion.

129 ntraocular lens in a private practice clinic were considered for inclusion.

130 CRP measurement should be considered for incorporation into prospective studies

131 This finding should be considered for individualized parental approaches and

132 arket-leading HCV viral load test and should be considered for instances where rapid near-to-patient

133 T is more convenient for patients and should be considered for intermediate-risk prostate cancer.

134 ages with and without attenuation correction were considered for interpretation.

135 ial candidates for liver transplantation and were considered for it upon detection of pejorative hist

136 easing diversity of engineered nanomaterials being considered for large-scale use, this high-throughp

137 ions in patients with CNS cancers and should be considered for liquid biopsies to monitor tumor evolu

138 estasis are unknown and patients continue to be considered for liver/multivisceral transplantation.

139 erformed, and patients with abnormal results were considered for liver biopsy.

140 Variables with p values of less than 0.1 were considered for logistic regression analysis to iden

141 cts between Sr and sediment that may need to be considered for long-term transport modeling.

142 monary fitness of a patient with lung cancer being considered for lung resection.

143 otic and suggests that IC antibiotics should be considered for M-SICS and phacoemulsification.

144 tical variable to assess in patients who are being considered for major surgery.

145 such as those with immunosuppression should be considered for management within multidisciplinary tu

146 included in the qualitative appraisal and 19 were considered for meta-analysis.

147 pression and function suggests that it could be considered for mitochondrial disease therapy and/or t

148 Two-way interactions between variables were considered for model inclusion if the interaction p

149 late-onset CMV infection/disease and should be considered for more intensive CMV viral load monitori

150 xisting as the oxyanion form of CrO4(2-), is being considered for more stringent drinking water stand

151 d on personal and family history alone would be considered for most (33 [52%] of 63; 95% CI, 40.3%-64

152 dicated for all symptomatic patients, should be considered for most asymptomatic patients, and is mor

153 f-stoichiometric LinBnHm (m </= 4n) clusters were considered for n = 2, 3, and 6.

154 ind all 22 Canadian hydroelectric facilities being considered for near-term development are located w

155 tumors that measure >20 mm at imaging should be considered for neoadjuvant treatment regardless of re

156 This drug class should be considered for nicotine addiction treatment.

157 It is of special importance in group D eyes being considered for nonsystemic treatment, such as prim

158 new class of epigenetic compounds that could be considered for novel strategies to counteract osteopo

159 alternate local treatment strategies should be considered for older, luminal B, and HER2 driven BC p

160 We find, when all seven models are considered for one representative concentration path

161 These patients should be considered for ongoing HCC surveillance.

162 and strength of immune responses and should be considered for optimizing current vaccination strateg

163 This should be considered for optimizing water treatment processes u

164 prioritised in these groups, but should also be considered for other children, especially those with

165 c conditions, opportunistic screening should be considered for p.[Cys282Tyr];[Cys282Tyr] individuals

166 to a dilemma regarding which patients should be considered for parathyroid surgery.

167 Most patients with pHPT should be considered for parathyroidectomy.

168 HIV-infected patients requiring HCT may also be considered for participation in trials evaluating the

169 IMPORTANCE Monocloncal antibodies (MAbs) are being considered for passive immunotherapy of HIV-1 infe

170 Thrombolysis should be considered for patients at low risk for bleeding who

171 py or 3 years of zoledronic acid therapy may be considered for patients at lower risk for fracture.

172 restaging generally is not suggested but can be considered for patients at risk for metastases or who

173 This intervention may be considered for patients exposed to potential epilepto

174 s not proven, so targeted therapy should not be considered for patients in this category which should

175 nd delayed repair of biliary injuries should be considered for patients presenting between 8 days and

176 Neoadjuvant imatinib therapy should be considered for patients requiring extensive surgery,

177 theless, treatment with anti-CD20 Abs should be considered for patients requiring transfusion with a

178 These findings should be considered for patients taking biotin supplements bef

179 Thus, this class of drugs should be considered for patients whose blood pressure remains

180 l-extracorporeal membrane oxygenation should be considered for patients with acute decompensated hear

181 The results suggest that lithium should be considered for patients with bipolar disorder with su

182 Statins may be considered for patients with elevated 10-year risk (>

183 The PVR-TIPS may be considered for patients with obliterative PVT who are

184 Chemotherapy should be considered for patients with positive lymph nodes, ER

185 herapies for other autoimmune diseases could be considered for patients with refractory disease.

186 Mutation screening of the FHL1 gene should be considered for patients with uncharacterized myopathi

187 ourse (3 months) of macrolide antibiotic may be considered for patients without polyps.

188 prehensive Cancer Network (NCCN) guidelines, is considered for patients with low-risk prostate cancer

189 ent for secondary bacterial infections could be considered for pneumonia cases even if a child tests

190 Therefore, if GSS testing is being considered for point-of-care diagnosis of N. gonor

191 This strategy should be considered for populations where compliance with FITs

192 IL-1beta antagonists should thus be considered for prevention and treatment of severe mor

193 These highly protective mAbs could be considered for prevention or treatment of CHIKV infec

194 blockade of the renin-angiotensin system may be considered for primary AF prevention in hypertensive

195 reased oral intake of cysteine may therefore be considered for primary or secondary prevention of vas

196 pecific targeting of SERCA2b by Tg analogues is considered for prostate cancer therapy, the inhibitio

197 irty-one studies that reported maxillary SMT were considered for qualitative analysis.

198 as input variables and twelve quality grades were considered for quality of fish as output variables

199 As such, the use of PVEC should be considered for quantitative (18)F-florbetaben PET sca

200 orrection for more accurate T1 values should be considered for quantitative dynamic contrast-enhanced

201 Patients being considered for radioembolization should undergo bo

202 Reasons are considered for radiology practices on both sides of

203 Several different waveguiding geometries are considered for reducing the effects of side-scatteri

204 is one of four metals/metalloids in tobacco being considered for regulation.

205 of metabotropic glutamate receptor 2 should be considered for relapse prevention.

206 y as recommended rescue treatments and could be considered for rescue treatment for Plasmodium falcip

207 y as recommended rescue treatments and could be considered for rescue treatment for Plasmodium falcip

208 Implications are considered for research in fields such as mechanisti

209 and consequently which brain regions should be considered for resection.

210 ft ventricular dysfunction and suspected CAD being considered for revascularization or transplantatio

211 for elements/radionuclides which may need to be considered for risk assessment of the agricultural fo

212 alternative rate correction formulas should be considered for routine electrocardiographic monitorin

213 geographically, HIV-infected children should be considered for RTS,S/AS01 vaccination.

214 east one dose of chemoprophylaxis or placebo were considered for safety, those receiving PfSPZ Challe

215 s; (4) trip blanks and spiked samples should be considered for samplers with short expiration times a

216 Persons without prior screening should be considered for screening up to age 85, depending on a

217 ely to benefit from VEGF inhibitors, FMT can be considered for second eyes with neovascular AMD.

218 It may be considered for selected high-risk patients.

219 olates, and species-level identification can be considered for selected noninvasive isolates to impro

220 matopoietic stem cell transplantation should be considered for selected patients with an optimal dono

221 with advanced renal dysfunction and HCC may be considered for SLK.

222 ality of life and therefore treatment should be considered for some children, especially those with m

223 y low enough for omission of radiotherapy to be considered for some patients.

224 the SSR in specific situations and it should be considered for SSR computation.

225 t increased atherosclerotic CVD risk and may be considered for statins.

226 can conclude that these methodologies should be considered for studies regarding seafood product auth

227 structure-antioxidant activity relationship was considered for studying the radical scavenging activ

228 Although trade-offs need to be considered for successful environmental management, t

229 egular narcotic use, patients with CD should be considered for surgical intervention.

230 do not wish to retain their fertility should be considered for surgical management.

231 als with medically refractory focal seizures being considered for surgical treatment.

232 in their institution and what methods should be considered for surveillance and detection of CR-NF.

233 ups of survivors, particularly males, should be considered for surveillance of cerebrovascular risk f

234 In these patients, catheter ablation is considered for symptom management or to treat tachyca

235 unidentified ligand-receptor systems should be considered for targeted drug development against huma

236 ts carried the greatest risk of AF and could be considered for targeted monitoring.

237 ctomy, radiation treatment, or both and were being considered for targeted therapy.

238 ting requires an understanding of who should be considered for testing and when it should be performe

239 , the combination of HMTis and HDACis should be considered for testing in animal models or clinical t

240 tablish CNS energy regulation as a factor to be considered for the development of better therapeutics

241 rmeability and activatable reactivity, could be considered for the development of protein-selective c

242 molecular and phenotypic test results should be considered for the diagnosis of MDR TB.

243 etabolic bioactivation uncovered here should be considered for the evaluation and design of clinical

244 complement those of Trx1 and must therefore be considered for the full understanding of enzymatic co

245 is an important prognostic factor and should be considered for the future edition of the TNM staging

246 nd as approved drugs in wide human use could be considered for the novel indication of human optic ne

247 define the particular requirements that must be considered for the nucleus to manage proteotoxic stre

248 It may be considered for the prognostic stratification of metas

249 ility and low cost, we suggest that CQ could be considered for the treatment and prophylaxis of ZIKV.

250 phoretic delivery of cytotoxic agents should be considered for the treatment of patients with unresec

251 estriction regimens, including fasting, have been considered for the prevention and treatment of cert

252 leukocytes, drugs against p110delta have not been considered for the treatment of solid tumours.

253 s in the management of patients requiring or being considered for the following clinical therapies: 1

254 novative biopharmaceutical agents, which are being considered for the therapy of cancer and chronic i

255 evaporation recycling within drainage basins is considered for the first time, which can reduce water

256 When both eyes were considered for the presence of RW-ROP, as would rou

257 Three levels of permeability were considered for the stoppers, ranging from 0.2 to 1.

258 uid-attenuated inversion recovery sequences, were considered for the study.

259 y Hospital from September 2013 to March 2016 were considered for the study.

260 More than 10,000 values were considered for the temperature determination for ea

261 and the adaptive immune system, which should be considered for therapeutic approaches of autoimmune d

262 tinin disease, or transformed disease should be considered for therapy.

263 Co-doped ZnO (ZnCoO) has been considered for these applications, but the origin o

264 SLN biopsy may be considered for thin melanomas that are T1b (0.8 to 1.

265 mmendations made about which patients should be considered for this intervention.

266 r DM, glycosylated hemoglobin testing should be considered for this purpose.

267 s were surveyed, and a total of 132 articles were considered for this review.

268 s they are diagnosed, and monotherapy should be considered for those in the low-mortality-score strat

269 rthermore, additional familial testing would be considered for those with first-degree relatives (42

270 eening for VGKCC, LGI1 and Caspr2 antibodies be considered for those with neuropsychiatric presentati

271 ne patients with severe mitral regurgitation being considered for transcatheter mitral valve implanta

272 use in patients with advanced heart failure being considered for transplant.

273 Organs from donors with ITP may be considered for transplantation, but livers should be

274 n patients with extensive comorbidity should be considered for transplantation.

275 ntation or is required to lose weight before being considered for transplantation.

276 Additional targets are considered for treating tardive dyskinesia and negat

277 the manipulation of CFTR gene topology could be considered for treating specific indications of cysti

278 The majority of patients with BCP will be considered for treatment during the pregnancy.

279 findings suggest that two strategies should be considered for treatment of any type of coronary ISR:

280 ich is widely available and inexpensive, can be considered for treatment of bacterial keratitis when

281 in PEG-b-PCL nanoparticle formulation should be considered for treatment of breast and other tumors.

282 inopathy progression, and fenofibrate should be considered for treatment of diabetic retinopathy.

283 rapidly ameliorate depression and could also be considered for treatment of insulin resistance in dep

284 patients, suggesting that lenvatinib should be considered for treatment of patients of any age with

285 ates that anti-EGFR MoAb therapy should only be considered for treatment of patients whose tumor is d

286 are settled, all patients with HR-CLL should be considered for treatment with BCRi/BCL2a.

287 izumab was effective in all cases and should be considered for treatment.

288 ly affecting cone photoreceptor function are being considered for treatment trials aiming to improve

289 e-related macular degeneration (AMD) who are being considered for treatment with antioxidants and zin

290 Percentage decline in eGFR should be considered for use as a surrogate outcome in kidney t

291 Nebulized epinephrine should be considered for use in future clinical studies of pati

292 levels measured in infant sera, and thus may be considered for use in lactating mothers.

293 lin-like growth factor receptor (IGF1R) have been considered for use in treating TNBC.

294 ration (59.2% w/w dm) and therefore it could be considered for utilisation of its fat content and for

295 Aqueous PCR should be considered for uveitis of atypical clinical appearanc

296 suggest that higher daptomycin doses need to be considered for VRE-BSI treatment.

297 k tumour-induced immune tolerance and should be considered for wider use in oncology.

298 icacy data for the leading candidate vaccine being considered for widespread use.

299 re represents an excellent option and should be considered for young and middle-aged adults undergoin

300 ls, suggesting that these parameters need to be considered for ZIKV vaccine design.